People · Operator
Named in public records as an officer, director or promoter · active 2010–2019 · Other Health Care, Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sonendo, Inc. | — | Other Health Care | Series C | $241.5M | $33.0M | 2013 |
| Adagio Medical, Inc. | — | Healthtech | Series C | $81.6M | $128.1M | 2013 |
| Metronom Health, Inc. | — | Healthtech | Series B | $48.6M | $476.9M | 2014 |
| Prelude Corp | — | Biotechnology | Series A | $40.9M | $13.8M | 2016 |
| LoneStar Heart, Inc. | — | Other Health Care | Series A | $25.2M | $84.4M | 2011 |
| Anaxiom Corp | — | Other Health Care | Series A | $9.5M | $19.7M | 2016 |
| Arges Imaging Inc. | — | Other Health Care | Pre-Seed | $855K | $26.4M | 2010 |
Hugh B. Neuharth at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Hugh B. Neuharth on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Olav B. Bergheim | 7 | 13 |
| Andrew B. Wade | 2 | 3 |
| Hugh Neuharth | 2 | 2 |
| Olav Bergheim | 2 | 2 |
| Charles Chungsik Chon | 2 | 2 |
| William J. Link | 1 | 10 |
| James Cox | 1 | 6 |
| Zach Scheiner | 1 | 6 |
| CHARLES CHON | 1 | 5 |
| Morteza Gharib | 1 | 5 |
| Raymond W. Cohen | 1 | 5 |
| Fan Yu | 1 | 4 |
| David Nikodem | 1 | 4 |
| Tuan Huynh | 1 | 2 |
| MICHAEL ZHAO | 1 | 2 |
| Anthony P. Bihl III | 1 | 2 |
| ANDREW COATS | 1 | 2 |
| Hugh A. Neuharth | 1 | 2 |
| Roy B. Cosan | 1 | 1 |
| Morteza B. Gharib | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.